Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.
$OGN
Organon & Co.
Organon & Co. is
a mid-cap
Pharmaceuticals: Major company in the Health Technology sector with a market cap of
$4B.
Health TechnologyPharmaceuticals: MajorstockStage 2 · AdvancingBase 1
$13.74latest close
Market Structure
Trend structure:range
Latest event:bos(bullish)
Inside
13.28–13.83
· 28 touches · strong
Momentum Turn Watch
Bollinger SqueezeBollinger band width (0.8%) is in the bottom quartile of its last 120 sessions — Legend's width-percentile squeeze (not a TTM/Keltner squeeze), so volatility is compressed and a sharper move often follows.
Early technical context only. Wait for price, volume, and the canonical setup trigger to confirm; this signal does not change readiness or the setup score.
QQQ, SMH moved against the stock — no index confirmation.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.
Position in 52-week range99thpercentile of the 52-week range
$5.69low
$13.83high
Pending acquisition — not a tradable setup.
OGN is being acquired by Sun Pharmaceutical Industries (Sun Pharma USA)
for $14.00 per share in cash
(announced Apr 26, 2026,
shareholder-approved Jul 23, 2026).
Upside is capped at the deal price and the chart's tightness reflects merger
arbitrage, not accumulation. Any pattern shown below is excluded from scan
rankings for this reason.
OGN Chart
Interactive price, volume, RS, RSI, and MACD charts are available after sign in.
Create a free account to load the full interactive chart for OGN.
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Base & Breakout
Breakout follow-through
No active breakout tracked — Legend AI monitors daily for pivot-point breaks.
What's a breakout?
RS Line vs SPY52-week relative strength · blue = RS line · dashed = MA50 · dot = NH
Accumulation / Distributionlast 65 sessions · green = acc on high vol · red = dist on high vol
Net +3
A+
No patterns detected
This symbol didn't match any pattern in the latest scan.
Minervini Trend Template
7/8
Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.
✓
Price above SMA 150 & 200$13.74 vs SMA150 $12.65 / SMA200 $11.41
✓
SMA 150 above SMA 200SMA150 $12.65 vs SMA200 $11.41
✓
SMA 200 trending upSlope +0.65 over 20 days
✓
SMA 50 above SMA 150 & 200SMA50 $13.73
✓
Price above SMA 50$13.74 vs SMA50 $13.73
✓
30%+ above 52-week low+141.5% from $5.69
✓
Within 25% of 52-week high-0.7% from $13.83
✗
RS score above 70RS 50
Fundamentals
52W Range
99%
Mkt Cap SEC
3.6B
EPS QoQ
+13%
Rev YoY
-3%
ROE
30%
Gross Margin
53%
D/E
11.49
EPS TTM
$0.72
P/E TTM
19.1x
Float
263M
Insider
No Buy
Company
Company profile
Organon & Co.
OGN · NYSE
· Health Technology
· Pharmaceuticals: Major